Stablix
Rishi Agrawal is a Scientist with experience at Stablix, Inc. and Denali Therapeutics, and has served as a Strategy Consultant for Biotech Connection - Bay Area, Inc. Rishi completed a Postdoctoral fellowship at Columbia University Irving Medical Center after earning a Ph.D. in Biomedical Sciences with a focus on Neuroscience and Cell Biology from Columbia University from 2014 to 2020. Rishi also holds a Bachelor of Science with Honors in Biochemistry and Molecular Biology from Penn State University, obtained in 2014.
Stablix
Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.